Nuveen Asset Management, LLC Genetron Holdings LTD Transaction History

Nuveen Asset Management, LLC

6 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2022 Aug 15, 2022	SELL	$1.28 - $2.4 $22,400 - $42,000	-17,500 Closed	0 $0
Q1 2022 May 16, 2022	SELL	$2.19 - $6.09 $2,847 - $7,917	-1,300 Reduced 6.91%	17,500 $38,000
Q4 2021 Feb 14, 2022	SELL	$5.81 - $14.39 $39,508 - $97,852	-6,800 Reduced 26.56%	18,800 $115,000
Q3 2021 Nov 12, 2021	BUY	$11.55 - $20.3 $65,835 - $115,710	5,700 Added 28.64%	25,600 $355,000
Q2 2021 Aug 16, 2021	SELL	$17.9 - $23.29 $452,869 - $589,237	-25,300 Reduced 55.97%	19,900 $401,000
Q4 2020 Feb 16, 2021	BUY	$9.31 - $14.0 $420,812 - $632,800	45,200 New	45,200 $633,000

7.5K

Ticker GTH
Exchange NASDAQ
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 90,602,304
Description
Genetron Holdings Limited, a precision oncology company, engages in the cancer molecular profiling, and harnessing technologies in molecular biology and data science for cancer treatment. The company offers diagnosis and monitoring services, and early screening services through laboratory developed tests services. It also provides in-vitro diagn...

Get notified when there are updates to the investment portfolio of Nuveen Asset Management, LLC, based on Form 13F filings with the SEC.

Stay updated on Nuveen Asset Management, LLC with notifications on news.